Cardica Inc (CRDC) 0.99 $CRDC
Cardica Launches New Curved Tip Cartridge/reload To Microcutter XCHANGE® 30 Surgical Stapler Product Line
PR Newswire - Tue Oct 21, 7:00AM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced the availability of the curved tip cartridge for its MicroCutter XCHANGE® 30 surgical stapling device. This cartridge has a curved atraumatic tip at the distal end which is designed to facilitate placement of the stapler on selected tissues. Cardica is currently offering the cartridge commercially on a limited release basis, with a global launch anticipated later this year.
CRDC: 0.99 (-0.01)
Cardica to Announce Fiscal 2015 First Quarter Financial Results on Tuesday, November 4, 2014
PR Newswire - Wed Oct 15, 7:00AM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced that it will release financial results for its fiscal first quarter ended September 30, 2014, on Tuesday, November 4, 2014, after the markets close. Cardica's management will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.
CRDC: 0.99 (-0.01)
Cardica Expands Board of Directors With Appointment of Two Experienced Medical Device Executives
PR Newswire - Tue Oct 14, 7:00AM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced the appointment of William Moffitt and Gary Petersmeyer to its board of directors, effective October 10, 2014. With these appointments, the Cardica Board expanded from six to eight members, seven of whom are independent.
CRDC: 0.99 (-0.01)
Cardica Introduces New Iteration Of MicroCutter XCHANGE® 30 Five-Millimeter Surgical Stapler
PR Newswire - Mon Sep 29, 7:00AM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced the introduction of a newly enhanced version of the MicroCutter XCHANGE® 30 surgical stapler, with the ability to clamp thicker tissue during a variety of surgical procedures. The XCHANGE 30 is the world's first and only five-millimeter surgical stapler that articulates to 80 degrees.
CRDC: 0.99 (-0.01)
Strength Seen in Cardica (CRDC): Stock Adds 7.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 8:25AM CDT
Cardica (CRDC) was a big mover last session, with shares rising nearly 8% on the day.
ICUI: 70.47 (+0.28), ABAX: 51.26 (+1.90), CRDC: 0.99 (-0.01), EGRX: 12.12 (+0.13)
Cardica Announces Fiscal 2014 Fourth Quarter And Full Year Financial Results
PR Newswire - Thu Aug 07, 3:05PM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced financial results for its fiscal fourth quarter and year ended June 30, 2014. Cardica's management will hold a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.
CRDC: 0.99 (-0.01)
Cardica To Present At 2014 Wedbush PacGrow Life Sciences Management Access Conference
PR Newswire - Mon Aug 04, 4:00PM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced that Bernard A. Hausen, M.D., Ph.D., the company's president and CEO, is scheduled to present a corporate overview and update at the 2014 Wedbush PacGrow Life Sciences Management Access Conference on Tuesday, August 12 at 12:45 p.m. Eastern Time.
CRDC: 0.99 (-0.01)
Cardica to Announce Fiscal 2014 Fourth Quarter and Full Year Financial Results on Thursday, August 7, 2014
PR Newswire - Wed Jul 23, 7:00AM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced that it will release financial results for its fiscal fourth quarter and year ended June 30, 2014, on Thursday, August 7, 2014, after the markets close. Cardica's management will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.
CRDC: 0.99 (-0.01)
Cardica Announces Data Presentation At Amazing Technologies Session Of 14th Annual World Congress Of Endoscopic Surgery
PR Newswire - Mon Jun 30, 12:02PM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced that Dr. Stefanos Demertzis, associate professor at the University of Berne, Switzerland and senior staff cardiac surgeon and deputy head of the department of cardiac surgery at the Cardiocentro Ticino Lugano, completed a study that demonstrated that there was no difference in the chronic healing response between the innovative D-shaped staple design of the Cardica five-millimeter MicroCutter XCHANGE® 30 and the B-shaped staple design used in conventional 12-millimeter surgical staplers.
CRDC: 0.99 (-0.01)
NICE Guidelines to Boost Boston Scientific's Rhythm Management - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 27, 2:00PM CDT
The new guidance released by NICE on use of cardiac technologies for arrhythmias and heart failure is expected to boost Boston Scientific Corporation's (BSX) Rhythm Management business in Europe.
BSX: 12.45 (+0.42), ICUI: 70.47 (+0.28), NURO: 1.75 (+0.01), CRDC: 0.99 (-0.01)
Haemonetics Suffers on Dismal Q4, Poor FY15 Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 27, 1:55PM CDT
On Jun 27, 2014, we issued an updated research report on Haemonetics Corporation (HAE).
ICUI: 70.47 (+0.28), NURO: 1.75 (+0.01), HAE: 34.74 (+0.34), CRDC: 0.99 (-0.01)
Medtronic's Cardiac Monitor Boosts AF Detection in Stroke Patients - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 26, 2:30PM CDT
Medtronic's (MDT) Reveal Insertable Cardiac Monitor possesses an algorithm to automatically detect AF as well as other cardiac arrhythmias.
ICUI: 70.47 (+0.28), MDT: 65.29 (+0.31), CRDC: 0.99 (-0.01), OSUR: 8.46 (unch)
Allscripts Healthcare's Sunrise EHR Platform Expansion on Track - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 26, 1:20PM CDT
Since Jan 2013, there have been 23 new Allscripts Sunrise commitments made by Allscripts Healthcare Solutions, Inc. (MDRX) at existing client facilities or at new organizations globally.
ICUI: 70.47 (+0.28), CRDC: 0.99 (-0.01), MDRX: 13.57 (+0.11), OSUR: 8.46 (unch)
Omeros Corporation (OMER) Gains: Stock Up 8.92% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jun 26, 7:44AM CDT
Omeros Corporation (OMER) was a big mover last session, as the company saw its shares rise 9% on the day.
ICUI: 70.47 (+0.28), NURO: 1.75 (+0.01), CRDC: 0.99 (-0.01), OMER: 12.27 (+0.15)
Quality Systems Teams Up With 3M Health Information Systems - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 12:50PM CDT
Quality Systems (QSII) continues to report a fall in earnings and revenues but we are still optimistic about the company given the continued strength in its NextGen subsidiary as well as the expected benefit from its Mirth acquisition.
NURO: 1.75 (+0.01), CRDC: 0.99 (-0.01), QSII: 14.07 (+0.16)
Cerner Enters New Agreement with North Carolina's Mission Health - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 12:40PM CDT
Under the new agreement, signed on Mar 28, Cerner Corporation (CERN) will help Mission Health control IT costs, align strategies, and improve the quality of care.
NURO: 1.75 (+0.01), CRDC: 0.99 (-0.01), CERN: 58.89 (-0.29)
Can The Uptrend Continue for Cardica (CRDC)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 8:10AM CDT
Can The Uptrend Continue for Cardica (CRDC)?
CRDC: 0.99 (-0.01)
LeMaitre Vascular (LMAT) Soars: Stock Adds 10.9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 7:51AM CDT
LeMaitre Vascular, Inc. (LMAT) was a big mover last session, as its shares rose nearly 11% on the day.
ICUI: 70.47 (+0.28), NURO: 1.75 (+0.01), LMAT: 6.80 (-0.10), CRDC: 0.99 (-0.01)
Bio-Rad Unveils Vitamin-D Test in International Market - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 24, 2:00PM CDT
Bio-Rad's(BIO) BioPlex 2200 system is the first and only fully-automated, random access multiplex testing system used for clinical diagnostic analyses.
ICUI: 70.47 (+0.28), BIO: 112.44 (-0.37), CRDC: 0.99 (-0.01), OSUR: 8.46 (unch)
Covidien Launches New PED to Treat Brain Aneurysm - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 24, 12:40PM CDT
Combining Covidien Plc.'s (COV) clinically-proven braid design with a new delivery system, the new PED offers enhanced accuracy and control while performing advanced surgical procedures on the brain.
MDT: 65.29 (+0.31), COV: 89.12 (-0.13), CRDC: 0.99 (-0.01), OSUR: 8.46 (unch)
Cardica Launches New Curved Tip Cartridge/reload To Microcutter XCHANGE® 30 Surgical Stapler Product Line
PR Newswire - Tue Oct 21, 7:00AM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced the availability of the curved tip cartridge for its MicroCutter XCHANGE® 30 surgical stapling device. This cartridge has a curved atraumatic tip at the distal end which is designed to facilitate placement of the stapler on selected tissues. Cardica is currently offering the cartridge commercially on a limited release basis, with a global launch anticipated later this year.
CRDC: 0.99 (-0.01)
Cardica to Announce Fiscal 2015 First Quarter Financial Results on Tuesday, November 4, 2014
PR Newswire - Wed Oct 15, 7:00AM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced that it will release financial results for its fiscal first quarter ended September 30, 2014, on Tuesday, November 4, 2014, after the markets close. Cardica's management will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.
CRDC: 0.99 (-0.01)
Cardica Expands Board of Directors With Appointment of Two Experienced Medical Device Executives
PR Newswire - Tue Oct 14, 7:00AM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced the appointment of William Moffitt and Gary Petersmeyer to its board of directors, effective October 10, 2014. With these appointments, the Cardica Board expanded from six to eight members, seven of whom are independent.
CRDC: 0.99 (-0.01)
Cardica Introduces New Iteration Of MicroCutter XCHANGE® 30 Five-Millimeter Surgical Stapler
PR Newswire - Mon Sep 29, 7:00AM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced the introduction of a newly enhanced version of the MicroCutter XCHANGE® 30 surgical stapler, with the ability to clamp thicker tissue during a variety of surgical procedures. The XCHANGE 30 is the world's first and only five-millimeter surgical stapler that articulates to 80 degrees.
CRDC: 0.99 (-0.01)
Strength Seen in Cardica (CRDC): Stock Adds 7.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 8:25AM CDT
Cardica (CRDC) was a big mover last session, with shares rising nearly 8% on the day.
ICUI: 70.47 (+0.28), ABAX: 51.26 (+1.90), CRDC: 0.99 (-0.01), EGRX: 12.12 (+0.13)
Cardica Announces Fiscal 2014 Fourth Quarter And Full Year Financial Results
PR Newswire - Thu Aug 07, 3:05PM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced financial results for its fiscal fourth quarter and year ended June 30, 2014. Cardica's management will hold a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.
CRDC: 0.99 (-0.01)
Cardica To Present At 2014 Wedbush PacGrow Life Sciences Management Access Conference
PR Newswire - Mon Aug 04, 4:00PM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced that Bernard A. Hausen, M.D., Ph.D., the company's president and CEO, is scheduled to present a corporate overview and update at the 2014 Wedbush PacGrow Life Sciences Management Access Conference on Tuesday, August 12 at 12:45 p.m. Eastern Time.
CRDC: 0.99 (-0.01)
Cardica to Announce Fiscal 2014 Fourth Quarter and Full Year Financial Results on Thursday, August 7, 2014
PR Newswire - Wed Jul 23, 7:00AM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced that it will release financial results for its fiscal fourth quarter and year ended June 30, 2014, on Thursday, August 7, 2014, after the markets close. Cardica's management will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.
CRDC: 0.99 (-0.01)
Cardica Announces Data Presentation At Amazing Technologies Session Of 14th Annual World Congress Of Endoscopic Surgery
PR Newswire - Mon Jun 30, 12:02PM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced that Dr. Stefanos Demertzis, associate professor at the University of Berne, Switzerland and senior staff cardiac surgeon and deputy head of the department of cardiac surgery at the Cardiocentro Ticino Lugano, completed a study that demonstrated that there was no difference in the chronic healing response between the innovative D-shaped staple design of the Cardica five-millimeter MicroCutter XCHANGE® 30 and the B-shaped staple design used in conventional 12-millimeter surgical staplers.
CRDC: 0.99 (-0.01)
NICE Guidelines to Boost Boston Scientific's Rhythm Management - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 27, 2:00PM CDT
The new guidance released by NICE on use of cardiac technologies for arrhythmias and heart failure is expected to boost Boston Scientific Corporation's (BSX) Rhythm Management business in Europe.
BSX: 12.45 (+0.42), ICUI: 70.47 (+0.28), NURO: 1.75 (+0.01), CRDC: 0.99 (-0.01)
Haemonetics Suffers on Dismal Q4, Poor FY15 Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 27, 1:55PM CDT
On Jun 27, 2014, we issued an updated research report on Haemonetics Corporation (HAE).
ICUI: 70.47 (+0.28), NURO: 1.75 (+0.01), HAE: 34.74 (+0.34), CRDC: 0.99 (-0.01)
Medtronic's Cardiac Monitor Boosts AF Detection in Stroke Patients - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 26, 2:30PM CDT
Medtronic's (MDT) Reveal Insertable Cardiac Monitor possesses an algorithm to automatically detect AF as well as other cardiac arrhythmias.
ICUI: 70.47 (+0.28), MDT: 65.29 (+0.31), CRDC: 0.99 (-0.01), OSUR: 8.46 (unch)
Allscripts Healthcare's Sunrise EHR Platform Expansion on Track - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 26, 1:20PM CDT
Since Jan 2013, there have been 23 new Allscripts Sunrise commitments made by Allscripts Healthcare Solutions, Inc. (MDRX) at existing client facilities or at new organizations globally.
ICUI: 70.47 (+0.28), CRDC: 0.99 (-0.01), MDRX: 13.57 (+0.11), OSUR: 8.46 (unch)
Omeros Corporation (OMER) Gains: Stock Up 8.92% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jun 26, 7:44AM CDT
Omeros Corporation (OMER) was a big mover last session, as the company saw its shares rise 9% on the day.
ICUI: 70.47 (+0.28), NURO: 1.75 (+0.01), CRDC: 0.99 (-0.01), OMER: 12.27 (+0.15)
Quality Systems Teams Up With 3M Health Information Systems - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 12:50PM CDT
Quality Systems (QSII) continues to report a fall in earnings and revenues but we are still optimistic about the company given the continued strength in its NextGen subsidiary as well as the expected benefit from its Mirth acquisition.
NURO: 1.75 (+0.01), CRDC: 0.99 (-0.01), QSII: 14.07 (+0.16)
Cerner Enters New Agreement with North Carolina's Mission Health - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 12:40PM CDT
Under the new agreement, signed on Mar 28, Cerner Corporation (CERN) will help Mission Health control IT costs, align strategies, and improve the quality of care.
NURO: 1.75 (+0.01), CRDC: 0.99 (-0.01), CERN: 58.89 (-0.29)
Can The Uptrend Continue for Cardica (CRDC)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 8:10AM CDT
Can The Uptrend Continue for Cardica (CRDC)?
CRDC: 0.99 (-0.01)
LeMaitre Vascular (LMAT) Soars: Stock Adds 10.9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 7:51AM CDT
LeMaitre Vascular, Inc. (LMAT) was a big mover last session, as its shares rose nearly 11% on the day.
ICUI: 70.47 (+0.28), NURO: 1.75 (+0.01), LMAT: 6.80 (-0.10), CRDC: 0.99 (-0.01)
Bio-Rad Unveils Vitamin-D Test in International Market - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 24, 2:00PM CDT
Bio-Rad's(BIO) BioPlex 2200 system is the first and only fully-automated, random access multiplex testing system used for clinical diagnostic analyses.
ICUI: 70.47 (+0.28), BIO: 112.44 (-0.37), CRDC: 0.99 (-0.01), OSUR: 8.46 (unch)
Covidien Launches New PED to Treat Brain Aneurysm - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 24, 12:40PM CDT
Combining Covidien Plc.'s (COV) clinically-proven braid design with a new delivery system, the new PED offers enhanced accuracy and control while performing advanced surgical procedures on the brain.
MDT: 65.29 (+0.31), COV: 89.12 (-0.13), CRDC: 0.99 (-0.01), OSUR: 8.46 (unch)
